Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel

被引：0
作者：
Andrea Fagiolini
José Ángel Alcalá
Thomas Aubel
Wojciech Bienkiewicz
Mats Magnus Knut Bogren
Joaquim Gago
Giancarlo Cerveri
Michael Colla
Francisco Collazos Sanchez
Alessandro Cuomo
Frieling Helge
Eduardo Iacoponi
Per-Axel Karlsson
Pradeep Peddu
Mauro Pettorruso
Henrique Jorge Ramos Pereira
Johan Sahlsten Schölin
Ingo Bernd Vernaleken
机构：
[1] University of Siena,School of Medicine, Department of Molecular Medicine
[2] Reina Sofia University Hospital,Clinical Unit of Mental Health
[3] Kliniken Essen-Mitte,Mental Health Department
[4] Klinik für Psychiatrie,Department of Mental Health and Addiction
[5] Psychotherapie,Clinic and Polyclinic for Psychiatry and Psychotherapy
[6] Psychosomatik und Suchtmedizin,Department of Psychiatry
[7] GGZ Keizersgracht Outpatient Mental Health Clinic,Department of Psychiatry and Forensic Medicine
[8] Divsion of Psychiatry,Department of Psychiatry, Social Psychiatry and Psychotherapy
[9] Department of Clinical Sciences,Lambeth Early Onset (LEO), South London & Maudsley NHS Foundation Trust and Psychosis Studies Department
[10] Lund University Hospital,Department of Neuroscience, Imaging and Clinical Sciences
[11] ,Department of Psychiatry and Psychotherapy
[12] Nova Medical School,Department of Psychiatry and Psychotherapy
[13] ASST Lodi,undefined
[14] University of Rostock,undefined
[15] Hospital Universitari Vall d’Hebron,undefined
[16] CIBERSAM,undefined
[17] Universitat Autònoma de Barcelona,undefined
[18] Hannover Medical School,undefined
[19] Institute of Psychiatry,undefined
[20] Psychology and Neurosciences,undefined
[21] Forensic Services of Norrbotten County Council,undefined
[22] Psychosis Pathway Coventry and Warwickshire Partnership NHS Trust and Buckingham Medical School,undefined
[23] D’Annunzio University of Chieti,undefined
[24] Hospital de Magalhães Lemos,undefined
[25] Sahlgrenska University Hospital,undefined
[26] Fliedner Krankenhaus Neunkirchen Kreuznacher Diakonie,undefined
[27] RWTH Aachen University,undefined
来源：
Annals of General Psychiatry | / 19卷
关键词：
Schizophrenia; Antipsychotics; Cariprazine; Patient subgroups; Recommendations; Negative symptoms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 76 条
  • [1] Kahn R(2015)Schizophrenia Nat Rev Dis Primers 1 15067-1858
  • [2] Sommer I(2018)Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. [Published correction appears in Lancet. 2019 Jun 22;393(10190):e44] Lancet. 392 1789-318
  • [3] Murray R(2018)The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses Ther Adv Psychopharmacol. 8 303-54
  • [4] Haddad PM(2012)Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries Bull World Health Organ 90 47-677
  • [5] Correll CU(2018)Negative symptoms of schizophrenia: new developments and unanswered research questions Lancet Psychiatry. 5 664-208
  • [6] Lora A(2017)Categorizing and assessing negative symptoms Curr Opin Psychiatry. 30 201-150
  • [7] Kohn R(2016)Treating Negative Symptoms in Schizophrenia: an Update Curr Treat Options Psychiatry. 3 133-531
  • [8] Levav I(2014)The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue Front Psychiatry 5 47-338
  • [9] McBain R(2006)Targeting the dopamine D2 receptor in schizophrenia Expert Opin Ther Targets. 10 515-206
  • [10] Galderisi S(2016)Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment) Drug Des Devel Ther. 10 327-693
12345678